top of page
< Back

201904-116095

2019

Fidelis Care New York

Medicaid

Central Nervous System/ Neuromuscular Disorder

Pharmacy/ Prescription Drugs

Medical necessity

Upheld

Case Summary

Diagnosis: Migraine headaches
Treatment: Ajovy
The proposed treatment with Ajovy is not medically necessary.
There are no high quality clinical trials or standard of care guidelines supporting the safety and efficacy of Ajovy when used as an adjuvant to Botox. The clinical trial leading to the FDA approval of Ajovy excluded persons who were actively treated with Botox at study commencement. Therefore, the safety and efficacy of Ajovy and an adjuvant to Botox remains undetermined.

bottom of page